Rabinovici R, Krausz M M, Feuerstein G
Department of Surgery, Jefferson Medical College, Philadelphia, Pennsylvania 19107.
Surg Gynecol Obstet. 1991 Aug;173(2):98-106.
Small volume hypertonic saline (HTS) solution resuscitation has been shown to restore hemodynamic derangements and to protect against mortality in "controlled" hemorrhagic shock (CHS), but it exacerbates the shock state in "uncontrolled" hemorrhagic shock (UCHS). To study the mechanisms associated with the divergent outcome of HTS treatment in CHS versus UCHS, HTS was administered to anesthetized rats (n = 7) subjected to 15 per cent resection of the tail followed by controlled or uncontrolled bleeding. HTS treatment of UCHS increased bleeding (13.3 +/- 1.6 milliliters, p less than 0.05), dropped mean arterial pressure (MAP) (-84.5 +/- 8.9 millimeters of mercury, p less than 0.001), central venous pressure (zero millimeters of mercury, p less than 0.001) and cardiac index (CI) (41 per cent of basal value, p less than 0.001) and increased acidosis (pH 7.23 +/- 0.12, p less than 0.05) and mortality (mean survival time 75 +/- 15 minutes versus 122 +/- 23 minutes of untreated rats, p less than 0.05). In contrast, when administered after application of a ligature proximal to the resection site (at 15 minutes), HTS completely reversed the changes in MAP, CI and total peripheral resistance index (TPRI), and improved mean survival time (172 +/- 7 minutes, p less than 0.05). These data support the assumption that HTS should be used in the treatment of hemorrhagic shock only after bleeding was controlled.
小容量高渗盐水(HTS)溶液复苏已被证明可恢复血流动力学紊乱,并预防“控制性”失血性休克(CHS)的死亡,但它会加重“非控制性”失血性休克(UCHS)的休克状态。为了研究与HTS治疗在CHS和UCHS中不同结果相关的机制,将HTS给予接受了15%尾切除并随后进行控制性或非控制性出血的麻醉大鼠(n = 7)。HTS治疗UCHS会增加出血量(13.3±1.6毫升,p<0.05),降低平均动脉压(MAP)(-84.5±8.9毫米汞柱,p<0.001)、中心静脉压(0毫米汞柱,p<0.001)和心脏指数(CI)(基础值的41%,p<0.001),并加重酸中毒(pH 7.23±0.12,p<0.05)和死亡率(平均生存时间为75±15分钟,而未治疗大鼠为122±23分钟,p<0.05)。相比之下,在切除部位近端应用结扎线后15分钟给予HTS时,HTS完全逆转了MAP、CI和总外周阻力指数(TPRI)的变化,并改善了平均生存时间(172±7分钟,p<0.05)。这些数据支持了这样一种假设,即仅在出血得到控制后才应使用HTS治疗失血性休克。